Asia Pacific clinical trials market will grow by 8.4% annually with a total addressable market cap of $97,110.8 million over 2023-2031, driven by the increasing number of clinical trials and increase ...

Asia Pacific active pharmaceutical ingredients (API) market will grow by 8.1% annually with a total addressable market cap of $ 1,098.6 billion over 2023-2032, driven by rising adoption of biologics ...